- Details
- 718
The Institute for Behavior and Health is pleased to share with you an interview of IBH President Robert L. DuPont, MD featured in Opioid Watch of The Opioid Research Institute:
[{{{type}}}] {{{reason}}}
{{/data.error.root_cause}}{{texts.summary}} {{#options.result.rssIcon}} RSS {{/options.result.rssIcon}}
{{/texts.summary}} {{#data.hits.hits}}{{{_source.displayDate}}}
{{/_source.showDate}}{{{_source.description}}}
{{#_source.additionalInfo}}{{#_source.additionalFields}} {{#title}} {{{label}}}: {{{title}}} {{/title}} {{/_source.additionalFields}}
{{/_source.additionalInfo}}
The RiverMend Health Website - RiverMend Health is a premier provider of evidence-based, scientifically driven addiction medicine delivering world-class treatment through our nationwide network of leading addiction recovery experts and treatment centers...
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services that leads public health efforts to advance the behavioral health of the nation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.
The Institute for Behavior and Health is pleased to share with you an interview of IBH President Robert L. DuPont, MD featured in Opioid Watch of The Opioid Research Institute:
Transmission of other bloodborne infections, particularly HIV and hepatitis B virus (HBV), is also increasing among injection-drug users, albeit at a slower rate. The opioid epidemic has also been linked to increasing rates of syphilis and other sexually transmitted infections, microbial endocarditis, and other infections associated with unsafe drug injection.3
The social and economic costs of the HCV epidemic could be staggering. Most injection-drug users who become infected with HCV do so as young adults. Such people are at risk for chronic hepatitis C and could face years of hefty health care expenses; left untreated, they may transmit HCV to others. The cost of caring for people with HCV places further strain on an already fragile health care system. Furthermore, because young adults are entering their most productive years, HCV will affect the economic productivity of the country for years to come. (DACA Comment – What is not included in this concerning report is that much of the increase in STI’s is not only due to the misuse of injecting equipment, but unsafe sexual activity engaged in whilst on the illicit drug, be it opioids or ATS. The ‘band aid’ of trying ‘manage’ the ‘disease’ of drug use with mechanisms that do not lead to exit from drug use, only add a further burden of disease and a comorbid condition, which is yet another epidemiological short coming of Harm Reduction ONLY ideologies and practices!)
JACC: Journal of the American College of Cardiology - Key Summary
PREVENTION ALLIANCE
Electronic cigarettes, or e-cigarettes, were invented in 2003 by Chinese inventor and pharmacist Hon Lik. Although many companies and advocates continue to bill them as a safer, smokeless alternative to traditional cigarettes, a U.S. Surgeon General report alarmingly found that 16% of high school students regularly use e-cigarettes. What’s worse, many young people who begin using nicotine through e-cigarettes will start to use traditional cigarettes later, according to the National Institute on Drug Abuse.
Smokers need help to quit, and those who can’t quit deserve a safer alternative. However, there’s a growing body of research indicating that e-cigarettes do more harm than good, and the companies selling them shamelessly advertise these products to youth in order to attract lifelong, valuable customers in ways that tobacco companies are prohibited from doing:
We support the Food and Drug Administration’s crackdown on e-cigarettes because with millions of teens using e-cigarettes every year, this is the beginning of an epidemic of nicotine addiction, and we invite you to learn more about these new nicotine delivery systems from the resources below.
March 6, 2018 - Abstract
Naloxone access may unintentionally increase opioid abuse through two channels: (1) saving the lives of active drug users, who survive to continue abusing opioids, and (2) reducing the risk of death per use, thereby making riskier opioid use more appealing. By increasing the number of opioid abusers who need to fund their drug purchases, Naloxone access laws may also increase theft. We exploit the staggered timing of Naloxone access laws to estimate the total effects of these laws. We find that broadening Naloxone access led to more opioid-related emergency room visits and more opioid-related theft, with no reduction in opioid-related mortality.